AETHLON MEDICAL, INC. Payments for Repurchase of Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- AETHLON MEDICAL, INC. payments for repurchase of equity for the quarter ending 2018-06-30 was $32.74K, a 75.95% decline year-over-year.
- AETHLON MEDICAL, INC. payments for repurchase of equity for the quarter ending 2018-03-31 was $80.11K, a 73.87% decline year-over-year.
- AETHLON MEDICAL, INC. payments for repurchase of equity for the quarter ending 2017-12-31 was $35.37K, a 660.56% increase year-over-year.
- AETHLON MEDICAL, INC. payments for repurchase of equity for the quarter ending 2017-09-30 was $27.03K, a 59.86% decline year-over-year.
- AETHLON MEDICAL, INC. payments for repurchase of equity for fiscal 2019 was $193.87K, a 30.42% decline from fiscal 2018.
- AETHLON MEDICAL, INC. payments for repurchase of equity for fiscal 2018 was $278.63K, a 26.39% decline from fiscal 2017.
- AETHLON MEDICAL, INC. payments for repurchase of equity for fiscal 2017 was $378.52K.
- AETHLON MEDICAL, INC. payments for repurchase of equity for fiscal 2016 was $0.00.
| Period end | Payments for Repurchase of Equity 3 month | Payments for Repurchase of Equity 12 month |
|---|---|---|
| 2019-03-31 | $193.87K 10-K · filed 2019-07-01 | |
| 2018-06-30 | $32.74K 10-Q · filed 2018-08-08 | $175.24K derived: sum of 4 quarters · filed 2019-07-01 |
| 2018-03-31 | $80.11K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-01 | $278.63K 10-K · filed 2019-07-01 |
| 2017-12-31 | $35.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-01 | $505.05K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-09-30 | $27.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-02 | $474.34K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-06-30 | $136.13K 10-Q · filed 2018-08-08 | $514.65K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $306.52K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-08 | $378.52K 10-K · filed 2018-06-08 |
| 2016-12-31 | $4.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-01 | $71.99K derived: sum of 4 quarters · filed 2018-02-01 |
| 2016-09-30 | $67.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-02 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-10 | |
| 2016-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | $0.00 10-K · filed 2017-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |